13F Insight
DOSSIER · 13F Holders · Q2 2025
BCLI

BRAINSTORM CELL THERAPEUTICS

1 institutions still hold BRAINSTORM CELL THERAPEUTICS as of Q2 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 10501E300·1 13F holders·last filed Jun 30, 2025
Market cap
—
13F value held
—
visible holders
Holders
1
filers reporting
Concentration
—
CONCOURSE FINANCIAL GROUP SECURITIES, INC. #1
top holder share
AI Holders Summary · Q2 2025

1 institutions reported BCLI in Q2 2025. Top-holder concentration data is loading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025
Insiders at BRAINSTORM CELL THERAPEUTICS
Pitts Peter Joe →Frenkel Jacob A →Yablonka Uri →Lebovits Chaim →Dagher Ibrahim B. →Naor Nir →Lindborg Stacy →Hartounian Hartoun →